Managing contacts of chlamydia: should clinics implement a test and wait process?

Current UK guidelines recommend treating all chlamydia contacts with empirical therapy during the look back period. However, some clinics have adopted a test and wait process for contacts presenting after 14 days of exposure. Prior research has shown that chlamydia transmission is common among sexual contacts, but the effectiveness of delayed testing remains unclear. This gap motivated an evaluation of whether a test and wait approach could be feasible in practice. No prior work had resolved whether delaying treatment affects reattendance rates or transmission risk. Established knowledge includes high prevalence of chlamydia in young populations and the importance of rapid treatment to prevent complications. This paper's contribution is to assess the real-world impact of a test and wait policy on clinic operations and patient outcomes. The study focuses on whether this alternative strategy could reduce unnecessary treatment while maintaining timely care.

The study aimed to evaluate the potential impact of implementing a test and wait process for chlamydia contacts at a sexual health clinic. The researchers wanted to determine if delaying treatment for contacts presenting after 14 days could reduce unnecessary empirical treatment without compromising care. The specific problem addressed is whether this approach would lead to higher reattendance rates or delays in treatment for confirmed cases. Motivation stemmed from the desire to align clinical practice with current guidelines while minimizing overtreatment. The researchers also sought to understand how patients responded to test results and how many follow-up attempts were needed to secure treatment attendance. By analyzing clinic data, they aimed to inform policy decisions about contact management. The study focused on whether a test and wait process could be safely adopted in a real-world setting. The results could help clinics decide whether to implement such a protocol.

The researchers conducted a retrospective service evaluation using patient records from a sexual health clinic. They reviewed data from 548 chlamydia contacts over one year and 588 patients with chlamydia over five months. Demographic and clinical data were collected for each case. The study focused on chlamydia prevalence among contacts and how it varied by age and sexual risk. Time since exposure was also analyzed to determine if it influenced infection rates. For patients with confirmed chlamydia, the team calculated the mean number of days between result notification and treatment attendance. They also tracked how many attempts were needed to contact patients for follow-up. The evaluation was based entirely on existing clinic records, avoiding the need for additional data collection. The goal was to assess the feasibility of a test and wait process in a real-world setting.

Chlamydia prevalence among contacts was 46%, with significant variation by age (p = .008) and sexual risk (p = .04). No significant difference was found by time since exposure (p = .29). For patients with chlamydia, the mean time between result notification and treatment attendance was 1.9 days. On average, 2.2 attempts were required to contact patients for treatment follow-up. Patients who tested positive returned promptly after being informed of their results. The study found that not providing empirical treatment to contacts presenting after 14 days would result in 13.1% of the cohort needing to return for treatment. This suggests a moderate increase in reattendance but not a complete failure of the test and wait approach. The data indicate that a test and wait process could be viable if patients are reliably contacted and follow up is ensured.

The authors suggest that a test and wait process for chlamydia contacts presenting after 14 days could be feasible in a clinical setting. Their findings indicate that chlamydia prevalence remains high in contacts regardless of time since exposure. The study proposes that delaying treatment does not significantly reduce the likelihood of reattendance for confirmed cases. The researchers note that patients with chlamydia typically return promptly once informed of their results. They suggest that a test and wait approach could reduce unnecessary empirical treatment without compromising patient outcomes. The data support the idea that a structured follow-up system could maintain care quality while minimizing overtreatment. The authors propose that clinics should consider implementing such a process if they have reliable systems for follow-up. These conclusions are based on the observed patterns of patient behavior and chlamydia prevalence in the study population.